Ashleigh Marie Guilbeau, MD
Family Practice · Lodi
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Valley Medical Foundation · 2,473 clinicians in this group
Looking this up.
Hospitals listed: Memorial Medical Center · Sutter Amador Hospital · Sutter Medical Center, Sacramento. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Guilbeau’s office at (209) 366-1990 to ask if they take your plan before you enroll.
California Medical Board record
Licence A140608 · Current
Licensed to practise in California · since 2016 · expires 2027-12-31 · Pennsylvania State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Sutter Amador HospitalJackson, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Amador Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 180 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.6 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 233 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 803 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,886 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,831 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.63 to 5.63) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.88 to 4.3) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.81 (0 to 1.84) · 1,604 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 138 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.9 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -27.8 · 230 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.5 · 226 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.1) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 14.9) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.1 to 18.6) · 146 cases | No different | Jan 2022 – Dec 2024 |
What patients said (385 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$101,847
Medicare paid this office $101,847 for 367 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 260 | $37,785 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 97 | $12,774 | $132 |
| Short return visit (20+ min) | 147 | $11,345 | $64 |
| Long return visit (40+ min) | 41 | $6,175 | $121 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $6,097 | $290 |
See all 12 services
| Return visit (30+ min) | 260 | $37,785 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 97 | $12,774 | $132 |
| Short return visit (20+ min) | 147 | $11,345 | $64 |
| Long return visit (40+ min) | 41 | $6,175 | $121 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $6,097 | $290 |
| Influenza vaccine, inactivated | 29 | $2,373 | $82 |
| New patient visit (45+ min) | 15 | $1,259 | $84 |
| Administration of influenza virus vaccine | 32 | $1,119 | $33 |
| Administration of pneumococcal vaccine | 22 | $724 | $33 |
| Injection of drug or substance under skin or into muscle | 13 | $293 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $232 | $10 |
| Automated urinalysis test | 18 | $42 | $2 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
367 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 11% · Women 81% · Also on Medicaid 12% · Health risk score 0.88. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 67% · Diabetes 26% · Chronic kidney disease 26% · Coronary heart disease 18% · Depression 18% · Heart failure 12% · Atrial fibrillation 12% · Cancer 11% · COPD 10% · Dementia 5% · Stroke 5%.
The office billed $352,670, Medicare allowed $136,556 and paid $101,847; for 1,787 services of 39 kinds; $25,299 of it was for drugs given in the office and $76,548 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 367 | 1,787 | 74 | 0.88 | $352,670 | $101,847 |
| 2023 | 324 | 1,402 | 74 | 0.85 | $304,426 | $88,728 |
| 2022 | 322 | 1,430 | 73 | 0.89 | $286,149 | $87,979 |
| 2021 | 322 | 821 | 74 | 0.79 | $189,283 | $59,390 |
| 2020 | 92 | 284 | 72 | 0.76 | $66,196 | $19,873 |
| 2019 | 66 | 182 | 76 | 0.99 | $41,964 | $15,923 |
| 2018 | 35 | 86 | 72 | 0.64 | $15,744 | $6,007 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 249 | $40,457 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 88 | $11,879 | $135 |
| Long return visit (40+ min) | 51 | $7,532 | $130 |
| Short return visit (20+ min) | 94 | $6,941 | $61 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 14 | $3,378 | $241 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 25 | $1,884 | $75 |
| New patient visit (45+ min) | 18 | $1,565 | $87 |
| Administration of influenza virus vaccine | 27 | $900 | $32 |
| Administration of pneumococcal vaccine | 22 | $707 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $386 | $12 |
| Automated urinalysis test | 15 | $35 | $2 |
2022: 13 services
| Return visit (30+ min) | 235 | $41,021 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 73 | $9,988 | $137 |
| Short return visit (20+ min) | 101 | $8,750 | $65 |
| Long return visit (40+ min) | 22 | $3,190 | $133 |
| New patient visit (45+ min) | 26 | $2,791 | $107 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 33 | $2,318 | $70 |
| Pneumococcal vaccine, 23-valent | 14 | $1,851 | $132 |
| Administration of influenza virus vaccine | 46 | $1,533 | $31 |
| New patient visit (30+ min) | 18 | $1,158 | $64 |
| Administration of pneumococcal vaccine | 25 | $816 | $31 |
| Influenza vaccine split virus, preservative free | 12 | $783 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $357 | $11 |
| Automated urinalysis test | 20 | $56 | $2 |
2021: 13 services
| Return visit (30+ min) | 216 | $28,720 | $97 |
| Short return visit (20+ min) | 98 | $7,453 | $68 |
| Long return visit (40+ min) | 34 | $5,626 | $148 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,988 | $138 |
| Pneumococcal vaccine, 23-valent | 18 | $2,261 | $126 |
| New patient visit (45+ min) | 22 | $2,210 | $100 |
| Influenza vaccine split virus, preservative free | 27 | $1,756 | $65 |
| New patient visit (30+ min) | 20 | $1,379 | $69 |
| Administration of influenza virus vaccine | 28 | $504 | $18 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $496 | $41 |
| Short return visit | 11 | $408 | $37 |
| Administration of pneumococcal vaccine | 21 | $378 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $311 | $11 |
2020: 6 services
| Return visit (30+ min) | 37 | $5,493 | $85 |
| Short return visit (20+ min) | 51 | $4,110 | $54 |
| New patient visit (45+ min) | 14 | $1,697 | $121 |
| New patient visit (30+ min) | 19 | $1,221 | $64 |
| Administration of pneumococcal vaccine | 13 | $229 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $143 | $13 |
2019: 3 services
| Short return visit (20+ min) | 38 | $3,546 | $61 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,156 | $137 |
| Return visit (30+ min) | 20 | $2,837 | $95 |
2018: 1 service
| Short return visit (20+ min) | 23 | $2,099 | $60 |
Drugs they prescribed that Part D paid
$267,709
Pharmacies billed $267,709 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (80 of 4,184) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
3,706 generic and 462 brand-name prescriptions · $267,709 in drug cost · 86 antibiotic prescriptions to 60 people · 13 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 45 | $41,929 | $932 |
| Trulicity | 26 | $31,527 | $1,213 |
| Nuedexta | 21 | $15,969 | $760 |
| Eliquis | 17 | $13,451 | $791 |
| Spiriva Respimat | 15 | $12,007 | $800 |
See all 81 drugs
| Ozempic | 45 | $41,929 | $932 |
| Trulicity | 26 | $31,527 | $1,213 |
| Nuedexta | 21 | $15,969 | $760 |
| Eliquis | 17 | $13,451 | $791 |
| Spiriva Respimat | 15 | $12,007 | $800 |
| Jardiance | 13 | $10,125 | $779 |
| Myrbetriq | 13 | $9,193 | $707 |
| Spiriva Handihaler | 11 | $5,416 | $492 |
| Basaglar Kwikpen U-100 | 13 | $4,477 | $344 |
| Atorvastatin | 373 | $3,788 | $10 |
| Levothyroxine | 284 | $3,114 | $11 |
| Arnuity Ellipta | 11 | $2,993 | $272 |
| Losartan | 188 | $1,797 | $10 |
| Synthroid | 34 | $1,763 | $52 |
| Bupropion | 39 | $1,337 | $34 |
| Estradiol | 24 | $1,335 | $56 |
| Potassium Chloride | 64 | $1,290 | $20 |
| Duloxetine | 35 | $1,209 | $35 |
| Ezetimibe | 18 | $1,191 | $66 |
| Albuterol Sulfate Hfa | 41 | $1,188 | $29 |
| Pantoprazole | 100 | $1,179 | $12 |
| Bupropion Xl | 32 | $1,161 | $36 |
| Escitalopram | 75 | $1,148 | $15 |
| Rosuvastatin | 58 | $1,144 | $20 |
| Ventolin Hfa | 17 | $1,135 | $67 |
| Amlodipine Besylate | 191 | $1,121 | $6 |
| Lisinopril | 159 | $1,052 | $7 |
| Hydrocodone-Acetaminophen | 56 | $1,049 | $19 |
| Venlafaxine Hcl Er | 35 | $1,043 | $30 |
| Gabapentin | 96 | $1,041 | $11 |
| Omeprazole | 85 | $1,039 | $12 |
| Valacyclovir | 34 | $993 | $29 |
| Metformin | 88 | $967 | $11 |
| Sertraline | 84 | $748 | $9 |
| Citalopram Hbr | 70 | $690 | $10 |
| Metoprolol | 61 | $672 | $11 |
| Lantus Solostar | 19 | $671 | $35 |
| Fluticasone Propionate | 30 | $632 | $21 |
| Pravastatin | 49 | $580 | $12 |
| Clopidogrel | 28 | $580 | $21 |
| Levetiracetam | 15 | $497 | $33 |
| Carvedilol | 62 | $477 | $8 |
| Benazepril | 22 | $453 | $21 |
| Montelukast | 42 | $446 | $11 |
| Simvastatin | 53 | $443 | $8 |
| Paroxetine | 18 | $394 | $22 |
| Alendronate | 30 | $387 | $13 |
| Pioglitazone | 20 | $368 | $18 |
| Trazodone | 57 | $354 | $6 |
| Losartan-Hydrochlorothiazide | 25 | $344 | $14 |
| Tamsulosin | 19 | $339 | $18 |
| Nystatin | 13 | $313 | $24 |
| Furosemide | 59 | $284 | $5 |
| Allopurinol | 20 | $276 | $14 |
| Glipizide Er | 13 | $259 | $20 |
| Zolpidem | 19 | $251 | $13 |
| Triamterene-Hydrochlorothiazid | 22 | $245 | $11 |
| Lisinopril-Hydrochlorothiazide | 28 | $242 | $9 |
| Ssd | 11 | $218 | $20 |
| Irbesartan | 12 | $216 | $18 |
| Cephalexin | 26 | $209 | $8 |
| Famotidine | 25 | $208 | $8 |
| Hydrocortisone | 11 | $190 | $17 |
| Buspirone | 54 | $179 | $3 |
| Diltiazem | 11 | $172 | $16 |
| Metformin Hcl Er | 37 | $168 | $5 |
| Naproxen | 17 | $160 | $9 |
| Sumatriptan | 23 | $145 | $6 |
| Metoprolol | 23 | $140 | $6 |
| Glipizide | 11 | $129 | $12 |
| Glimepiride | 13 | $117 | $9 |
| Donepezil | 14 | $99 | $7 |
| Fluconazole | 14 | $96 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $96 | $9 |
| Pregabalin | 18 | $90 | $5 |
| Alprazolam | 20 | $88 | $4 |
| Tramadol | 24 | $80 | $3 |
| Hydrochlorothiazide | 18 | $69 | $4 |
| Acyclovir | 12 | $50 | $4 |
| Sulfamethoxazole-Trimethoprim | 13 | $32 | $2 |
| Prednisone | 11 | $23 | $2 |
Year by year
| 2024 | 4,184 | 404 | 2% (80) | 11% | $267,709 |
| 2023 | 3,994 | 346 | 1% (53) | 10% | $311,984 |
| 2022 | 3,822 | 331 | 2% (78) | None | $266,382 |
| 2021 | 1,592 | 266 | 4% (63) | None | $123,729 |
| 2020 | 411 | 86 | None | None | $39,191 |
| 2019 | 250 | 42 | 0% (0) | 15% | $9,165 |
| 2018 | 100 | 24 | 0% (0) | 15% | $3,293 |
| 2017 | 334 | 44 | 8% (28) | None | $21,046 |
| 2016 | 231 | 38 | 10% (24) | 21% | $10,382 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 79 drugs
| Trulicity | 35 | $41,251 | $1,179 |
| Ozempic | 22 | $26,233 | $1,192 |
| Eliquis | 17 | $15,484 | $911 |
| Lantus Solostar | 29 | $14,295 | $493 |
| Spiriva Respimat | 17 | $13,029 | $766 |
| Myrbetriq | 14 | $6,798 | $486 |
| Spiriva Handihaler | 12 | $6,480 | $540 |
| Lantus | 11 | $5,430 | $494 |
| Arnuity Ellipta | 18 | $4,900 | $272 |
| Atorvastatin | 336 | $4,320 | $13 |
| Levothyroxine | 277 | $4,047 | $15 |
| Losartan | 169 | $2,859 | $17 |
| Diclofenac Sodium-Misoprostol | 13 | $2,470 | $190 |
| Ezetimibe-Simvastatin | 16 | $2,235 | $140 |
| Omeprazole | 96 | $1,777 | $19 |
| Lisinopril | 161 | $1,768 | $11 |
| Rosuvastatin | 56 | $1,717 | $31 |
| Potassium Chloride | 72 | $1,706 | $24 |
| Pregabalin | 26 | $1,680 | $65 |
| Synthroid | 20 | $1,515 | $76 |
| Estradiol | 16 | $1,438 | $90 |
| Amlodipine Besylate | 166 | $1,373 | $8 |
| Bupropion | 54 | $1,320 | $24 |
| Ventolin Hfa | 14 | $1,302 | $93 |
| Escitalopram | 84 | $1,215 | $14 |
| Metoprolol | 70 | $1,197 | $17 |
| Metformin | 109 | $1,099 | $10 |
| Bupropion Xl | 11 | $1,055 | $96 |
| Famotidine | 24 | $995 | $41 |
| Pantoprazole | 72 | $995 | $14 |
| Gabapentin | 57 | $966 | $17 |
| Duloxetine | 26 | $940 | $36 |
| Albuterol Sulfate Hfa | 41 | $900 | $22 |
| Sertraline | 82 | $889 | $11 |
| Pravastatin | 46 | $805 | $17 |
| Citalopram Hbr | 83 | $799 | $10 |
| Alendronate | 49 | $797 | $16 |
| Sumatriptan | 37 | $789 | $21 |
| Metformin Hcl Er | 55 | $774 | $14 |
| Venlafaxine Hcl Er | 34 | $738 | $22 |
| Ezetimibe | 12 | $734 | $61 |
| Pioglitazone | 25 | $722 | $29 |
| Memantine | 22 | $719 | $33 |
| Fluticasone Propionate | 25 | $692 | $28 |
| Carbamazepine Er | 52 | $630 | $12 |
| Carvedilol | 45 | $628 | $14 |
| Simvastatin | 62 | $555 | $9 |
| Clopidogrel | 33 | $554 | $17 |
| Liothyronine | 11 | $550 | $50 |
| Montelukast | 36 | $513 | $14 |
| Losartan-Hydrochlorothiazide | 26 | $483 | $19 |
| Mirtazapine | 12 | $480 | $40 |
| Trazodone | 60 | $472 | $8 |
| Valacyclovir | 23 | $462 | $20 |
| Hydrocodone-Acetaminophen | 34 | $458 | $13 |
| Paroxetine | 20 | $429 | $21 |
| Levetiracetam | 15 | $420 | $28 |
| Ondansetron | 22 | $404 | $18 |
| Allopurinol | 20 | $397 | $20 |
| Lisinopril-Hydrochlorothiazide | 23 | $360 | $16 |
| Triamterene-Hydrochlorothiazid | 16 | $353 | $22 |
| Ssd | 14 | $337 | $24 |
| Benazepril | 22 | $334 | $15 |
| Glipizide | 11 | $230 | $21 |
| Doxycycline Hyclate | 13 | $229 | $18 |
| Donepezil | 19 | $228 | $12 |
| Furosemide | 41 | $218 | $5 |
| Tamsulosin | 12 | $215 | $18 |
| Hydrochlorothiazide | 27 | $204 | $8 |
| Tramadol | 16 | $202 | $13 |
| Glimepiride | 17 | $198 | $12 |
| Ibuprofen | 21 | $183 | $9 |
| Irbesartan | 17 | $175 | $10 |
| Nitrofurantoin Mono-Macro | 11 | $146 | $13 |
| Naproxen | 12 | $138 | $11 |
| Buspirone | 29 | $132 | $5 |
| Cephalexin | 23 | $111 | $5 |
| Metoprolol | 21 | $93 | $4 |
| Alprazolam | 23 | $55 | $2 |
2022: 77 drugs
| Trulicity | 23 | $32,063 | $1,394 |
| Eliquis | 27 | $19,425 | $719 |
| Lantus Solostar | 19 | $14,361 | $756 |
| Spiriva Respimat | 15 | $11,681 | $779 |
| Spiriva Handihaler | 11 | $5,854 | $532 |
| Arnuity Ellipta | 21 | $5,332 | $254 |
| Symbicort | 11 | $5,263 | $478 |
| Levothyroxine | 268 | $4,584 | $17 |
| Serevent Diskus | 11 | $4,536 | $412 |
| Lantus | 13 | $4,094 | $315 |
| Atorvastatin | 296 | $3,460 | $12 |
| Pregabalin | 28 | $2,180 | $78 |
| Potassium Chloride | 60 | $1,939 | $32 |
| Omeprazole | 99 | $1,915 | $19 |
| Pioglitazone | 35 | $1,792 | $51 |
| Bupropion Xl | 21 | $1,745 | $83 |
| Ezetimibe | 12 | $1,713 | $143 |
| Losartan | 134 | $1,684 | $13 |
| Rosuvastatin | 61 | $1,645 | $27 |
| Lisinopril | 148 | $1,304 | $9 |
| Ventolin Hfa | 16 | $1,298 | $81 |
| Metoprolol | 73 | $1,249 | $17 |
| Bupropion | 56 | $1,202 | $21 |
| Metformin | 113 | $1,194 | $11 |
| Albuterol Sulfate Hfa | 29 | $1,194 | $41 |
| Amlodipine Besylate | 221 | $1,193 | $5 |
| Hydrocodone-Acetaminophen | 40 | $1,121 | $28 |
| Synthroid | 13 | $1,015 | $78 |
| Mirtazapine | 20 | $826 | $41 |
| Pantoprazole | 52 | $793 | $15 |
| Gabapentin | 48 | $787 | $16 |
| Escitalopram | 67 | $777 | $12 |
| Clopidogrel | 41 | $726 | $18 |
| Citalopram Hbr | 84 | $704 | $8 |
| Duloxetine | 21 | $617 | $29 |
| Metformin Hcl Er | 41 | $616 | $15 |
| Estradiol | 19 | $602 | $32 |
| Carvedilol | 34 | $579 | $17 |
| Carbamazepine Er | 34 | $573 | $17 |
| Simvastatin | 72 | $563 | $8 |
| Ondansetron | 23 | $543 | $24 |
| Memantine | 28 | $503 | $18 |
| Alendronate | 53 | $495 | $9 |
| Montelukast | 25 | $487 | $19 |
| Morphine Sulfate Er | 13 | $479 | $37 |
| Pravastatin | 26 | $444 | $17 |
| Levetiracetam | 16 | $441 | $28 |
| Sumatriptan | 48 | $433 | $9 |
| Chlorthalidone | 12 | $431 | $36 |
| Triamterene-Hydrochlorothiazid | 32 | $410 | $13 |
| Venlafaxine Hcl Er | 18 | $396 | $22 |
| Sertraline | 51 | $396 | $8 |
| Liothyronine | 13 | $389 | $30 |
| Trazodone | 52 | $362 | $7 |
| Lisinopril-Hydrochlorothiazide | 27 | $354 | $13 |
| Metoprolol | 30 | $310 | $10 |
| Tamsulosin | 11 | $306 | $28 |
| Allopurinol | 20 | $294 | $15 |
| Irbesartan | 14 | $271 | $19 |
| Glimepiride | 13 | $270 | $21 |
| Furosemide | 42 | $257 | $6 |
| Nitrofurantoin Mono-Macro | 18 | $245 | $14 |
| Fluticasone Propionate | 19 | $233 | $12 |
| Spironolactone | 20 | $228 | $11 |
| Donepezil | 19 | $208 | $11 |
| Benazepril | 26 | $195 | $7 |
| Atenolol | 19 | $193 | $10 |
| Valacyclovir | 15 | $189 | $13 |
| Cyclobenzaprine | 18 | $172 | $10 |
| Hydrochlorothiazide | 40 | $159 | $4 |
| Tramadol | 16 | $129 | $8 |
| Cephalexin | 15 | $117 | $8 |
| Ibuprofen | 12 | $80 | $7 |
| Naproxen | 17 | $79 | $5 |
| Zolpidem | 16 | $73 | $5 |
| Sulfamethoxazole-Trimethoprim | 14 | $52 | $4 |
| Acyclovir | 14 | $36 | $3 |
2021: 40 drugs
| Trulicity | 13 | $20,749 | $1,596 |
| Eliquis | 30 | $18,613 | $620 |
| Xarelto | 13 | $9,968 | $767 |
| Levothyroxine | 103 | $2,390 | $23 |
| Atorvastatin | 127 | $1,837 | $14 |
| Gabapentin | 47 | $1,149 | $24 |
| Rosuvastatin | 24 | $898 | $37 |
| Estradiol | 19 | $894 | $47 |
| Losartan | 64 | $851 | $13 |
| Hydrocodone-Acetaminophen | 29 | $832 | $29 |
| Potassium Chloride | 12 | $575 | $48 |
| Omeprazole | 32 | $553 | $17 |
| Venlafaxine Hcl Er | 11 | $542 | $49 |
| Metoprolol | 30 | $505 | $17 |
| Amlodipine Besylate | 84 | $500 | $6 |
| Metformin | 45 | $498 | $11 |
| Ondansetron | 14 | $496 | $35 |
| Duloxetine | 13 | $494 | $38 |
| Bupropion | 21 | $453 | $22 |
| Morphine Sulfate Er | 12 | $428 | $36 |
| Albuterol Sulfate Hfa | 13 | $404 | $31 |
| Lisinopril | 45 | $374 | $8 |
| Pantoprazole | 21 | $360 | $17 |
| Simvastatin | 34 | $356 | $10 |
| Fluticasone Propionate | 15 | $325 | $22 |
| Pregabalin | 16 | $302 | $19 |
| Escitalopram | 34 | $296 | $9 |
| Clopidogrel | 12 | $245 | $20 |
| Pioglitazone | 11 | $231 | $21 |
| Trazodone | 29 | $221 | $8 |
| Citalopram Hbr | 21 | $204 | $10 |
| Atenolol | 15 | $169 | $11 |
| Hydrochlorothiazide | 13 | $154 | $12 |
| Metformin Hcl Er | 17 | $123 | $7 |
| Alendronate | 13 | $120 | $9 |
| Sertraline | 17 | $120 | $7 |
| Furosemide | 13 | $115 | $9 |
| Buspirone | 11 | $77 | $7 |
| Tramadol | 12 | $74 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $30 | $3 |
2020: 10 drugs
| Xarelto | 13 | $8,740 | $672 |
| Atorvastatin | 37 | $680 | $18 |
| Metoprolol | 16 | $550 | $34 |
| Simvastatin | 11 | $325 | $30 |
| Levothyroxine | 13 | $296 | $23 |
| Losartan | 18 | $236 | $13 |
| Fluticasone Propionate | 12 | $212 | $18 |
| Hydrochlorothiazide | 18 | $191 | $11 |
| Amlodipine Besylate | 24 | $164 | $7 |
| Lisinopril | 14 | $110 | $8 |
2019: 4 drugs
| Atorvastatin | 20 | $479 | $24 |
| Alendronate | 13 | $354 | $27 |
| Hydrochlorothiazide | 11 | $122 | $11 |
| Lisinopril | 14 | $104 | $7 |
2018: 1 drug
| Lisinopril | 14 | $67 | $5 |
2017: 7 drugs
| Polyethylene Glycol 3350 | 11 | $202 | $18 |
| Atorvastatin | 28 | $191 | $7 |
| Pravastatin | 13 | $140 | $11 |
| Amlodipine Besylate | 24 | $73 | $3 |
| Lisinopril | 15 | $65 | $4 |
| Ranitidine | 12 | $49 | $4 |
| Ibuprofen | 11 | $48 | $4 |
Money from drug and device companies
$135 in 2020
A payment is not proof that care is biased.
| Pfizer | Prevnar 13 | $54 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $28 | 2 payments
|
| Amgen | Aimovig | $20 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $13 | 1 payment
|
See all 7 published payments
| Kowa Pharmaceuticals America | Meals · 2020-07-09 | Livalo | $16 |
| Pfizer | Meals · 2020-06-22 | Prevnar 13 | $34 |
| Merck Sharp & Dohme | Meals · 2020-06-17 | Januvia | $19 |
| Pfizer | Meals · 2020-05-08 | Eliquis | $20 |
| Kowa Pharmaceuticals America | Meals · 2020-04-16 | Livalo | $12 |
| Amgen | Meals · 2020-03-12 | Aimovig | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2020-03-02 | Farxiga | $13 |
Professional record
- NPI
- 1912311069
- Licence
- CA A140608California A140608: Current · expires 2027-12-31
- Trained
- Pennsylvania State University College of Medicine, 2014
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- Po Box 255228, Sacramento, CA, 95865
- NPI first listed
- 2014-06-17
- NPI last updated
- 2020-01-06
- NPI record certified
- 2020-01-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 455 Oconnor Dr, San Jose, CA, 95128